Skip to main content
Autobound logo
Cerus CorporationSEC 10-Q

BARDA Agreement Extensions Executed in July 2026 Extending Red Blood Cell Funding to 2027 and 2031

Read at SEC EDGAR

What happened

In July 2026, Cerus entered into an amendment to extend its 2016 BARDA Agreement through March 2027 and a modification to extend the 2024 BARDA Agreement through September 2031.

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 10-Q

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Nov 2, 2026

More from Cerus Corporation

More SEC 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
1020214
Accession number
0001193125-26-443694
Timeframe
Multi year
Quarter
Q3
Filing year
2026
Fiscal year end
09/30
Period end date
Sep 30, 2026
Why it matters
Scaling needs
Signal category
Revenue

Topics and mentions

Regions named

  • U.S.

Technologies named

  • INTERCEPT Blood System

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Nov 3, 2026
signal_type
sec-10q
signal_subtype
majorContractWin

Use this data

Get every SEC 10-Q signal for Cerus Corporation and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Cerus Corporation this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns SEC 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/a4e4044f-f3cf-443c-8140-da8f33c38d49 returns this record as JSON. POST /v1/companies/enrich returns every signal for cerus.com.

{
  "signal_id": "a4e4044f-f3cf-443c-8140-da8f33c38d49",
  "signal_type": "sec-10q",
  "signal_subtype": "majorContractWin",
  "detected_at": "2026-11-03T07:04:14.843+00:00",
  "company": {
    "name": "Cerus Corporation",
    "domain": "cerus.com"
  },
  "data": {
    "detail": "In July 2026, Cerus entered into an amendment to extend its 2016 BARDA Agreement through March 2027 and a modification to extend the 2024 BARDA Agreement through September 2031. This provides ongoing government funding support for clinical and regulatory development programs, which may create opportunities for clinical research services and specialized biopharma suppliers.",
    "metrics": {
      "timeframe": "multi_year"
    },
    "quarter": "Q3",
    "summary": "BARDA Agreement Extensions Executed in July 2026 Extending Red Blood Cell Funding to 2027 and 2031",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1020214/000119312526443694/cers-20260930.htm",
    "filing_date": "2026-11-02",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Scaling needs",
    "signal_category": "revenue",
    "regions_mentioned": [
      "U.S."
    ],
    "technologies_mentioned": [
      "INTERCEPT Blood System"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.